fibrinolysins activate
纖維蛋白溶解酶活化
administering fibrinolysins
給予纖維蛋白溶解酶
fibrinolysin levels
纖維蛋白溶解酶水平
measuring fibrinolysins
測量纖維蛋白溶解酶
fibrinolysin treatment
纖維蛋白溶解酶治療
inhibiting fibrinolysins
抑制纖維蛋白溶解酶
fibrinolysins degrade
纖維蛋白溶解酶降解
detecting fibrinolysins
檢測纖維蛋白溶解酶
fibrinolysin activity
纖維蛋白溶解酶活性
increased fibrinolysins
增加的纖維蛋白溶解酶
researchers are investigating the potential of fibrinolysins for treating ischemic stroke.
研究人員正在探討溶栓酶在治療缺血性中風方面的潛力。
fibrinolysins can effectively dissolve blood clots in the circulatory system.
溶栓酶可以有效溶解循環系統中的血塊。
the development of novel fibrinolysins is a key area of pharmaceutical research.
新型溶栓酶的開發是藥物研究的關鍵領域。
administering fibrinolysins requires careful monitoring of patient coagulation status.
給予溶栓酶需要仔細監測患者的凝血狀態。
engineered fibrinolysins offer improved efficacy and reduced bleeding risks.
工程化溶栓酶可提供更高的療效並降低出血風險。
fibrinolysins' mechanism of action involves the breakdown of fibrin networks.
溶栓酶的作用機制涉及纖維蛋白網絡的分解。
clinical trials are evaluating the safety and efficacy of recombinant fibrinolysins.
臨床試驗正在評估重組溶栓酶的安全性和有效性。
the rapid onset of action is a significant advantage of certain fibrinolysins.
某些溶栓酶的快速起效是其重要優勢。
understanding fibrinolysins' interactions with other clotting factors is crucial.
了解溶栓酶與其他凝血因子的交互作用至關重要。
fibrinolysins are being explored as a potential treatment for deep vein thrombosis.
溶栓酶正被探討作為深靜脈血栓的潛在治療方法。
the stability of fibrinolysins in storage is an important consideration for manufacturers.
溶栓酶在儲存過程中的穩定性是製造商的重要考量。
fibrinolysins activate
纖維蛋白溶解酶活化
administering fibrinolysins
給予纖維蛋白溶解酶
fibrinolysin levels
纖維蛋白溶解酶水平
measuring fibrinolysins
測量纖維蛋白溶解酶
fibrinolysin treatment
纖維蛋白溶解酶治療
inhibiting fibrinolysins
抑制纖維蛋白溶解酶
fibrinolysins degrade
纖維蛋白溶解酶降解
detecting fibrinolysins
檢測纖維蛋白溶解酶
fibrinolysin activity
纖維蛋白溶解酶活性
increased fibrinolysins
增加的纖維蛋白溶解酶
researchers are investigating the potential of fibrinolysins for treating ischemic stroke.
研究人員正在探討溶栓酶在治療缺血性中風方面的潛力。
fibrinolysins can effectively dissolve blood clots in the circulatory system.
溶栓酶可以有效溶解循環系統中的血塊。
the development of novel fibrinolysins is a key area of pharmaceutical research.
新型溶栓酶的開發是藥物研究的關鍵領域。
administering fibrinolysins requires careful monitoring of patient coagulation status.
給予溶栓酶需要仔細監測患者的凝血狀態。
engineered fibrinolysins offer improved efficacy and reduced bleeding risks.
工程化溶栓酶可提供更高的療效並降低出血風險。
fibrinolysins' mechanism of action involves the breakdown of fibrin networks.
溶栓酶的作用機制涉及纖維蛋白網絡的分解。
clinical trials are evaluating the safety and efficacy of recombinant fibrinolysins.
臨床試驗正在評估重組溶栓酶的安全性和有效性。
the rapid onset of action is a significant advantage of certain fibrinolysins.
某些溶栓酶的快速起效是其重要優勢。
understanding fibrinolysins' interactions with other clotting factors is crucial.
了解溶栓酶與其他凝血因子的交互作用至關重要。
fibrinolysins are being explored as a potential treatment for deep vein thrombosis.
溶栓酶正被探討作為深靜脈血栓的潛在治療方法。
the stability of fibrinolysins in storage is an important consideration for manufacturers.
溶栓酶在儲存過程中的穩定性是製造商的重要考量。
探索常見搜尋詞彙